(*) CA Approval Date: 2020. 09.29.
(*) EU Approval Date: 2023. 03.03
(*) USA Approval Date: 2019. 11.08.
>Erythroid Maturation Agent for Inj
Company
Generic Name: Luspatercept for Inj.
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2021. 05.18
RTM
RTM Web-Site